Compass Research

The Villages, Florida 32162

0 studies enrolling now · 10 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Alzheimer´s Disease, Parkinson's Disease, Respiratory Syncytial Virus Infections, Smoking

Studies at this site

• A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) — Completed
• A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD — Completed
• Evaluation of Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 for 26 Weeks — Completed
• A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease — Completed
• A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 — Completed
• RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults — Completed
• A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). — Stopped early
• An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease — Stopped early
• A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease — Completed
• A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease — Completed